Insider Buying: Odyssey Therapeutics (NASDAQ:ODTX) Director Acquires 5,000 Shares of Stock

Odyssey Therapeutics, Inc. (NASDAQ:ODTX – Get Free Report) Director Jeffrey Leiden acquired 5,000 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The shares were bought at an average cost of $20.00 per share, for a total transaction of $100,000.00. Following the acquisition, the director directly owned 270,198 shares in the company, valued at $5,403,960. This represents a 1.89% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Odyssey Therapeutics Stock Performance

NASDAQ ODTX traded up $1.03 during trading hours on Monday, hitting $17.45. The company had a trading volume of 426,992 shares. Odyssey Therapeutics, Inc. has a 52 week low of $15.35 and a 52 week high of $20.30.

Further Reading

• Five stocks we like better than Odyssey Therapeutics
• Before the Moon Base Gets Built, These 4 Companies Win
• Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
• 3 Stocks That Win If Inflation Surprises to the Downside
• MercadoLibre Boldly Invests in Growth: Discount Deepens